SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paul D. Miller, Edward F. McCarthy, Bisphosphonate-associated atypical sub-trochanteric femur fractures: Paired bone biopsy quantitative histomorphometry before and after teriparatide administration, Seminars in Arthritis and Rheumatism, 2015, 44, 5, 477

    CrossRef

  2. 2
    Knut Skoglund, Olav Hjortdal, Femurfraktur og kjeveleddsdestruksjon etter bruk av bisfosfonater, Tidsskrift for Den norske legeforening, 2015, 135, 2, 116

    CrossRef

  3. 3
    T. L. N. Järvinen, K. Michaëlsson, P. Aspenberg, H. Sievänen, Osteoporosis: the emperor has no clothes, Journal of Internal Medicine, 2015, 277, 6
  4. 4
    Gun-Il Im, Seung-Hyo Jeong, Pathogenesis, Management and Prevention of Atypical Femoral Fractures, Journal of Bone Metabolism, 2015, 22, 1, 1

    CrossRef

  5. 5
    Michael Pazianas, Se-min Kim, Tony Yuen, Li Sun, Sol Epstein, Mone Zaidi, Questioning the association between bisphosphonates and atypical femoral fractures, Annals of the New York Academy of Sciences, 2015, 1335, 1
  6. 6
    Jörg Schilcher, Veronika Koeppen, Per Aspenberg, Karl Michaëlsson, Risk of atypical femoral fracture during and after bisphosphonate use, Acta Orthopaedica, 2015, 86, 1, 100

    CrossRef

  7. 7
    Z. Wang, M. M. Ward, L. Chan, T. Bhattacharyya, Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries, Osteoporosis International, 2014, 25, 8, 2109

    CrossRef

  8. 8
    Alejandro Marcano, David Taormina, Kenneth A. Egol, Valerie Peck, Nirmal C. Tejwani, Are Race and Sex Associated With the Occurrence of Atypical Femoral Fractures?, Clinical Orthopaedics and Related Research®, 2014, 472, 3, 1020

    CrossRef

  9. 9
    Yougun Won, Joon-Ryul Lim, Young-Hwan Kim, Hyung-keun Song, Kyu Hyun Yang, Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate, Journal of Bone Metabolism, 2014, 21, 2, 155

    CrossRef

  10. 10
    Per Aspenberg, Jörg Schilcher, Atypical Femoral Fractures, Bisphosphonates, and Mechanical Stress, Current Osteoporosis Reports, 2014, 12, 2, 189

    CrossRef

  11. 11
    Joseph Borrelli, Joseph Lane, Susan Bukata, Kenneth A. Egol, Richelle Takemoto, Gerard Slobogean, Saam Morshed, Atypical Femur Fractures, Journal of Orthopaedic Trauma, 2014, 28, S36

    CrossRef

  12. You have free access to this content12
    Elizabeth Shane, David Burr, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David W Dempster, Peter R Ebeling, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Tet Sen Howe, Marjolein CH van der Meulen, Robert S Weinstein, Michael P Whyte, Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research, 2014, 29, 1
  13. 13
    Thomas A. Einhorn, Yelena Bogdan, Paul Tornetta, Bisphosphonate-Associated Fractures of the Femur, Journal of Orthopaedic Trauma, 2014, 28, 7, 433

    CrossRef

  14. 14
    Jie Liu, Hong-xin Zhang, Xiong-xiong Lu, Jia-jia Hu, Lian-fu Deng, Bisphosphonates and Risk of Subtrochanteric, Femoral Shaft, and Atypical Femur Fracture: Sensitivity and Trim and Fill Studies, Genetic Testing and Molecular Biomarkers, 2014, 18, 2, 117

    CrossRef

  15. 15
    Angela G. Juby, Sean Crowther, Marilyn Cree, Identifying Atypical Femoral Fractures—A Retrospective Review, Calcified Tissue International, 2014, 95, 5, 405

    CrossRef

  16. 16
    Alvin C. Ng, Meng Ai Png, David T. Chua, Joyce S. B. Koh, Tet Sen Howe, Review: Epidemiology and Pathophysiology of Atypical Femur Fractures, Current Osteoporosis Reports, 2014, 12, 1, 65

    CrossRef

  17. 17
    E. Suresh, M. Pazianas, B. Abrahamsen, Safety issues with bisphosphonate therapy for osteoporosis, Rheumatology, 2014, 53, 1, 19

    CrossRef

  18. 18
    Yoto Oh, Yoshiaki Wakabayashi, Yoshiro Kurosa, Masafumi Ishizuki, Atsushi Okawa, Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series, Journal of Orthopaedic Science, 2014, 19, 4, 579

    CrossRef

  19. 19
    Yoshitomo Saita, Muneaki Ishijima, Atsuhiko Mogami, Mitsuaki Kubota, Tomonori Baba, Takefumi Kaketa, Masashi Nagao, Yuko Sakamoto, Kensuke Sakai, Rui Kato, Nana Nagura, Kei Miyagawa, Tomoki Wada, Lizu Liu, Osamu Obayashi, Katsuo Shitoto, Masahiko Nozawa, Hajime Kajihara, Hogaku Gen, Kazuo Kaneko, The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment, Bone, 2014, 66, 105

    CrossRef

  20. 20
    Lisa Markman, Mary Allison, Zehava Rosenberg, Renata Vieira, James Babb, Nirmal Tejwani, Shelly Im, Valerie Peck, A Retrospective Review of Patients with Atypical Femoral Fractures While on Long-Term Bisphosphonates: Including Pertinent Biochemical and Imaging Studies, Endocrine Practice, 2013, 19, 3, 456

    CrossRef

  21. 21
    Jörg Schilcher, Veronika Koeppen, Jonas Ranstam, Ralf Skripitz, Karl Michaëlsson, Per Aspenberg, Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls, Bone, 2013, 52, 1, 389

    CrossRef

  22. 22
    Clifford B. Jones, Atypical Femoral Fractures: An Orthopaedic Surgeon’s Perspective, Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2, 2, 91

    CrossRef

  23. 23
    Anas Saleh, Vishal V. Hegde, Anish G. Potty, Joseph M. Lane, Bisphosphonate Therapy and Atypical Fractures, Orthopedic Clinics of North America, 2013, 44, 2, 137

    CrossRef

  24. 24
    Michael McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen, E. Michael Lewiecki, Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday, The American Journal of Medicine, 2013, 126, 1, 13

    CrossRef

  25. 25
    Lydia Gedmintas, Daniel H Solomon, Seoyoung C Kim, Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis, Journal of Bone and Mineral Research, 2013, 28, 8
  26. 26
    A. LeBlanc, T. Matsumoto, J. Jones, J. Shapiro, T. Lang, L. Shackelford, S. M. Smith, H. Evans, E. Spector, R. Ploutz-Snyder, J. Sibonga, J. Keyak, T. Nakamura, K. Kohri, H. Ohshima, Bisphosphonates as a supplement to exercise to protect bone during long-duration spaceflight, Osteoporosis International, 2013, 24, 7, 2105

    CrossRef

  27. 27
    Jörg Schilcher, Epidemiology, radiology and histology of atypical femoral fractures, Acta Orthopaedica, 2013, 84, S352, 1

    CrossRef

  28. 28
    Malachi J. McKenna, Susan van der Kamp, Eric Heffernan, Conor Hurson, Incomplete Atypical Femoral Fractures: Assessing the Diagnostic Utility of DXA by Extending Femur Length, Journal of Clinical Densitometry, 2013, 16, 4, 579

    CrossRef

  29. 29
    Bruce Ettinger, Cynthia A. Stuenkel, Peter F. Schnatz, Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture, Menopause, 2013, 20, 10, 1092

    CrossRef

  30. 30
    Chang-Wug Oh, Jong-Keon Oh, Ki-Chul Park, Joon-Woo Kim, Yong-Cheol Yoon, Prophylactic Nailing of Incomplete Atypical Femoral Fractures, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  31. 31
    M.B. Allison, L. Markman, Z. Rosenberg, R.L. Vieira, J. Babb, N. Tejwani, V. Peck, RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy, Bone, 2013, 55, 1, 113

    CrossRef

  32. 32
    Paola Franceschetti, Marta Bondanelli, Gaetano Caruso, Maria Rosaria Ambrosio, Vincenzo Lorusso, Maria Chiara Zatelli, Leo Massari, Ettore C degli Uberti, Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy, Bone, 2013, 56, 2, 426

    CrossRef

  33. 33
    Anne Pernille Hermann, Bo Abrahamsen, The bisphosphonates: risks and benefits of long term use, Current Opinion in Pharmacology, 2013, 13, 3, 435

    CrossRef

  34. 34
    Paul Kostenuik, Osteoporosis, 2013,

    CrossRef

  35. 35
    Elizabeth Shane, Sundeep Khosla, David Burr, Osteoporosis, 2013,

    CrossRef

  36. 36
    Eve Donnelly, Anas Saleh, Aasis Unnanuntana, Joseph M. Lane, Atypical femoral fractures, Current Opinion in Supportive and Palliative Care, 2012, 6, 3, 348

    CrossRef

  37. 37
    Bo Abrahamsen, Atypical femur fractures: Refining the clinical picture, Journal of Bone and Mineral Research, 2012, 27, 5
  38. 38
    Bo Abrahamsen, Thomas A. Einhorn, Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures, Bone, 2012, 50, 5, 1196

    CrossRef

  39. 39
    Dima L. Diab, Nelson B. Watts, Bisphosphonates in the Treatment of Osteoporosis, Endocrinology and Metabolism Clinics of North America, 2012, 41, 3, 487

    CrossRef

  40. 40
    Anders Rydholm, Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed!, Acta Orthopaedica, 2012, 83, 4, 319

    CrossRef

  41. 41
    Richard M Dell, Annette L Adams, Denise F Greene, Tadashi T Funahashi, Stuart L Silverman, Eric O Eisemon, Hui Zhou, Raoul J Burchette, Susan M Ott, Incidence of atypical nontraumatic diaphyseal fractures of the femur, Journal of Bone and Mineral Research, 2012, 27, 12
  42. 42
    Catalina Orozco, Naim M. Maalouf, Safety of Bisphosphonates, Rheumatic Disease Clinics of North America, 2012, 38, 4, 681

    CrossRef